News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
George Vlachogiannis: A major driver of morbidity and poor outcomes in advanced NSCLC
medpagetoday.com
Apr 8, 2025, 08:03

George Vlachogiannis: A major driver of morbidity and poor outcomes in advanced NSCLC

George Vlachogiannis, Managing Editor at Cancer Control, shared a post on LinkedIn:

“A comprehensive clinicogenomic analysis of data from ~4,000 patients with lung adenocarcinoma (LUAD) obtained from the MSK MetTropism cohort identifies key clinical and genetic markers associated with bone metastases—a major driver of morbidity and poor outcomes in advanced NSCLC.

Key findings:

  •  Bone metastases were linked to specific co-metastases (e.g., liver, CNS) and mutations in TP53, EGFR, KEAP1, and MYC.
  •  Poor prognosis in bone metastatic LUAD was associated with age >75, female sex, EGFR wild-type status, and mutations in KEAP1, MYC, KRAS, and SMARCA4.

Observations can improve risk stratification and inform targeted monitoring strategies.”

Lung Adenocarcinoma With Bone Metastases: Clinicogenomic Profiling and Insights Into Prognostic Factors

Authors: Ahmed H. Al Sharie et al.

George Vlachogiannis: A major driver of morbidity and poor outcomes in advanced NSCLC

Ahmed H. Al Sharie cancer George Vlachogiannis health medicine NSCLC OncoDaily Oncology
Special Coverage
Blog
May 28, 2025, 20:09
Nita Radhakrishnan: Register for the 10th MIDTERM PHO CME 2025
Insight
May 28, 2025, 20:03
Upcoming Event on Women Leaders in T-Cell Lymphoma Research Shared by Vallabhaneni Sree Harshitha
Blog
May 28, 2025, 17:18
Yan Leyfman: Performance Evaluation of an AI-powered System For Clinical Trial Eligibility Using mCODE Data Standards
Blog
May 28, 2025, 16:50
Mahmoud Hammad Shares SIOP-Africa Education and Training Committee Lecture on How to Approach a Febrile Neutropenic Patient
Blog
May 28, 2025, 16:43
Tanja Obradovic Highlights Positive ASCENT-03 Results for Trodelvy Ahead of ASCO 2025
Blog
May 28, 2025, 16:05
ASCO and NCODA Release Updated Standards for Medically Integrated Dispensing Pharmacy
Blog
May 28, 2025, 15:18
Dinesh Raj Neupane Talked about Financial Toxicity of Cancer at the Public Health Conference
Blog
May 28, 2025, 15:05
Roberto Borea: Excited to Represent the International Society of Liquid Biopsy at ASCO 2025
Opinion
May 28, 2025, 14:57
Amanda Bilbrey Highlights the Role of Oncology Nurses: Celebrating Oncology Nursing Month 2025
Blog
May 28, 2025, 14:51
Nazik Hammad: Great Afternoon with Ophira Ginsburg Discussing the Future of Global Oncology
Blog
May 28, 2025, 14:36
Daiichi Sankyo at ASCO 2025: Markus Kosch on Advancing Patient Outcomes Through Scientific Innovation
Blog
May 28, 2025, 14:20
Massive Bio at ASCO 2025 Annual Meeting